Acceleron Pharma Inc.
Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels

Last updated:

Abstract:

In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.

Status:
Grant
Type:

Utility

Filling date:

19 Feb 2020

Issue date:

10 Nov 2020